Genetics of Hearing Loss in Middle Eastern Families

描述（由申请人提供）：该项目的目标是发现和表征在高度信息化的中东地区的遗传性听力障碍（HHI）的基因。在这些近亲家庭中发现的基因对非近亲的美国聋人群体很重要，因为HHI的所有基因都阐明了听力生物学的普遍特征，并且因为这些基因经常携带其他突变，导致世界各地人群中的隐性或显性HHI。到目前为止，我们已经将DFNA 15鉴定为POU 4F 3，DFNB 30鉴定为MYO 3A，并且现在将DFNB 28鉴定为塔拉的新同种型，我们将其命名为OTO塔拉。我们正在开发MYO 3A/DFNB 30无义突变的小鼠模型。在另外两个kinetics中，我们将听力损失的基因定位到染色体2 q31和11q14.3-q21上的小间隔。这些区域没有已知的耳聋基因，因此这些激酶将揭示两个新的HHI基因。在另外四个家庭中，我们发现了已知耳聋基因的新等位基因，这表明该人群的遗传性听力损失与其他地方相似。在我们的项目中登记的156个HHI家庭中，GJB 2（连接蛋白26）仅在17个（11%）家庭中负责HHI，反映了由于其他基因导致的HHI的高频率。在该项目的下一个周期，我们的合作建议： (1)为了进一步表征野生型和突变型OTOTARA， (2)确定染色体2 q31和11q14.3-q21上隐性、非综合征HHI的基因 (3)在另外四个基因组中进行HHI基因的定位鉴定 (4)完成MYO 3A/DFNB 30基因敲入小鼠并表征其表型 这种合作的优势是在项目中的热情参与扩展的信息kinetics与HHI，大量的这些kinetics可能携带突变，在迄今为止未知的听力相关基因，和我们证明成功的映射，识别和表征基因HHI在这些家庭。

DESCRIPTION (provided by applicant): The goal of this project is to find and characterize genes responsible for hereditary hearing impairment (HHI) in highly informative Middle Eastern kindreds. Genes identified in these consanguineous families are important to the non-consanguineous U.S. deaf population because all genes for HHI illuminate universal features of hearing biology and because such genes often harbor other mutations leading to recessive or dominant HHI in populations worldwide. We have thus far identified DFNA15 as POU4F3, DFNB30 as MYO3A, and now DFNB28 as a novel isoform of TARA, which we name OTOTARA. We are developing a mouse model of the MYO3A/DFNB30 nonsense mutation. In two other kindreds, we mapped genes for hearing loss to small intervals on chromosomes 2q31 and 11q14.3-q21. These regions do not harbor known deafness genes, so these kindreds will reveal two more novel genes for HHI. In four other families, we identified new alleles of known deafness genes, suggesting that genetic hearing loss in this population is similar to that elsewhere. In the 156 families with HHI enrolled in our project, GJB2 (connexin 26) is responsible for HHI in only 17 (11%) of families, reflecting the high frequency of HHI due to other genes. In the next cycle of this project, our collaboration proposes: (1) to further characterize wildtype and mutant OTOTARA (2) to identify genes for recessive, nonsyndromic HHI on chromosomes 2q31 and 11q14.3-q21 (3) to undertake positional identification of genes for HHI in four additional kindreds (4) to complete the MYO3A/DFNB30 knock-in mouse and characterize its phenotype The strengths of this collaboration are the enthusiastic participation in the project of extended informative kindreds with HHI, the large number of these kindreds likely to carry mutations in heretofore unknown hearing-related genes, and our demonstrated success in mapping, identifying, and characterizing genes for HHI in these families.